Use of ECMO in ARDS: does the EOLIA trial really help?
Use of ECMO in ARDS: does the EOLIA trial really help?
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
[...]taking the cross-over rate into account, and considering that the survival rate of the crossed-over patients without ECMO would have been between 0 and 33%, one finds a significant increase in relative risk reduction with ECMO (from 0.74 to 0.62, p < 0.001 and p = 0.045, respectively) compared to the relative risk reduction of 0.76 (p = 0.09)...
Alternative Titles
Full title
Use of ECMO in ARDS: does the EOLIA trial really help?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6afe19aaf58f4b3c807b7664462e73f6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6afe19aaf58f4b3c807b7664462e73f6
Other Identifiers
ISSN
1364-8535
E-ISSN
1364-8535,1466-609X,1366-609X
DOI
10.1186/s13054-018-2098-6
